SEVERE ALOPECIA AREATA
Clinical trials for SEVERE ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new SEVERE ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for SEVERE ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
3-Year trial tests if hair loss drug keeps working for kids
Disease control Recruiting nowThis study aims to learn about the long-term safety and effectiveness of the medicine ritlecitinib for treating severe alopecia areata, a condition that causes significant hair loss. It is for children and teenagers who have already finished one of two previous Pfizer studies for…
Matched conditions: SEVERE ALOPECIA AREATA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Major drug study tracks safety of new hair loss treatment
Disease control Recruiting nowThis study is monitoring the safety and effectiveness of Litfulo capsules in real-world patients with severe alopecia areata (an autoimmune condition causing significant hair loss). It will enroll 3,000 patients in Korea who are already prescribed the medication to track side eff…
Matched conditions: SEVERE ALOPECIA AREATA
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for kids with severe hair loss: major trial tests daily pill
Disease control Recruiting nowThis study is testing whether a daily pill called ritlecitinib can help regrow scalp hair in children aged 6 to 12 who have lost at least half their hair due to severe alopecia areata. About 225 children will be randomly assigned to receive either one of two doses of the study me…
Matched conditions: SEVERE ALOPECIA AREATA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC